Publication | Open Access
Incidence and Predictors of Esophagogastric Varices Bleeding in Patients with Hepatocellular Carcinoma in Lenvatinib
10
Citations
14
References
2023
Year
In hepatocellular carcinoma patients treated with lenvatinib, the risk of EGV bleeding was mostly low but significant only in patients with high-risk EGV at baseline.
| Year | Citations | |
|---|---|---|
Page 1
Page 1